IP Library › Assignment 033181/0693
Patent Assignment
Reel/Frame 033181/0693

Assignment of Assignor's Interest

Recorded: 2014-06-09 Pages: 6
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (6)
BETA2-Adrenergic Receptor Agonists
Application: 09/457,618 →
BETA2-Adrenergic Receptor Agonists
Patent: 6,576,793 →
Application: 09/637,899 →
BETA2-Adrenergic Receptor Agonists
Patent: 6,916,961 →
Application: 10/108,945 →
Publication: US 2003/0087307
BETA2-Adrenergic Receptor Agonists
Patent: 7,217,738 →
Application: 11/049,447 →
Publication: US 2005/0261338
BETA2-Adrenergic Receptor Agonists
Patent: 7,427,639 →
Application: 11/784,148 →
Publication: US 2007/0179179
Beta2-Adrenergic Receptor Agonists
Application: 12/145,658 →
Publication: US 2008/0269344
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2001
From: MORAN, EDMOND J.; GRIFFIN, JOHN H.; CHOI, SEOK-KI
To: ADVANCED MEDICINE, INC.
Reel/Frame 011431/0444 →
Merger Jun 13, 2002
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 013017/0267 →